Massimo Santonastaso

1.8k total citations
36 papers, 1.3k citations indexed

About

Massimo Santonastaso is a scholar working on Cardiology and Cardiovascular Medicine, Nutrition and Dietetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Massimo Santonastaso has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 11 papers in Nutrition and Dietetics and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Massimo Santonastaso's work include Blood Pressure and Hypertension Studies (24 papers), Sodium Intake and Health (11 papers) and Heart Rate Variability and Autonomic Control (10 papers). Massimo Santonastaso is often cited by papers focused on Blood Pressure and Hypertension Studies (24 papers), Sodium Intake and Health (11 papers) and Heart Rate Variability and Autonomic Control (10 papers). Massimo Santonastaso collaborates with scholars based in Italy, United States and Switzerland. Massimo Santonastaso's co-authors include Paolo Palatini, Lucio Mos, Achille C. Pessina, Paolo Mormino, Giuseppe Zanata, Francesca Dorigatti, Marta Dal Follo, Francesca Saladini, Cristina Canali and Italia Papparella and has published in prestigious journals such as Kidney International, Hypertension and European Heart Journal.

In The Last Decade

Massimo Santonastaso

36 papers receiving 1.3k citations

Peers

Massimo Santonastaso
Francesca Dorigatti Italy
Ann C. Hewkin United States
Alessandro Mattina Italy
Wille Oigman Brazil
Moo‐Yong Rhee South Korea
Aldona Wierzbicka Poland
Dion Zappe United States
Kimberly F. Stitzel United States
Annette Champion United States
Eric Judd United States
Francesca Dorigatti Italy
Massimo Santonastaso
Citations per year, relative to Massimo Santonastaso Massimo Santonastaso (= 1×) peers Francesca Dorigatti

Countries citing papers authored by Massimo Santonastaso

Since Specialization
Citations

This map shows the geographic impact of Massimo Santonastaso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Santonastaso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Santonastaso more than expected).

Fields of papers citing papers by Massimo Santonastaso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Santonastaso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Santonastaso. The network helps show where Massimo Santonastaso may publish in the future.

Co-authorship network of co-authors of Massimo Santonastaso

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Santonastaso. A scholar is included among the top collaborators of Massimo Santonastaso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Santonastaso. Massimo Santonastaso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palatini, Paolo, Giulio Ceolotto, Fabio Ragazzo, et al.. (2012). Phosducin rs12402521 polymorphism predicts development of hypertension in young subjects with overweight or obesity. Nutrition Metabolism and Cardiovascular Diseases. 23(4). 323–329. 3 indexed citations
2.
Saladini, Francesca, Massimo Santonastaso, Lucio Mos, et al.. (2011). Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low. Journal of Hypertension. 29(7). 1311–1319. 37 indexed citations
3.
Saladini, Francesca, Francesca Dorigatti, Massimo Santonastaso, et al.. (2009). Natural History of Hypertension Subtypes in Young and Middle-Age Adults. American Journal of Hypertension. 22(5). 531–537. 28 indexed citations
4.
Palatini, Paolo, Giulio Ceolotto, Fabio Ragazzo, et al.. (2009). CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. Journal of Hypertension. 27(8). 1594–1601. 158 indexed citations
5.
Palatini, Paolo, Elisabetta Benetti, Massimo Santonastaso, et al.. (2009). Cystatin C as Predictor of Microalbuminuria in the Early Stage of Hypertension. Nephron Clinical Practice. 113(4). c309–c314. 14 indexed citations
6.
Sartori, Michelangelo, Giulio Ceolotto, Francesca Dorigatti, et al.. (2008). RGS2 C1114G polymorphism and body weight gain in hypertensive patients. Metabolism. 57(3). 421–427. 15 indexed citations
7.
Palatini, Paolo, Giulio Ceolotto, Francesca Dorigatti, et al.. (2008). Angiotensin II Type 1 Receptor Gene Polymorphism Predicts Development of Hypertension and Metabolic Syndrome. American Journal of Hypertension. 22(2). 208–214. 34 indexed citations
8.
Palatini, Paolo, Francesca Dorigatti, Massimo Santonastaso, et al.. (2007). Association between coffee consumption and risk of hypertension. Annals of Medicine. 39(7). 545–553. 38 indexed citations
9.
Palatini, Paolo, Paolo Mormino, Francesca Dorigatti, et al.. (2006). Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: The HARVEST. Kidney International. 70(3). 578–584. 78 indexed citations
10.
Winnicki, Mikołaj, Virend K. Somers, Francesca Dorigatti, et al.. (2006). Lifestyle, family history and progression of hypertension. Journal of Hypertension. 24(8). 1479–1487. 34 indexed citations
11.
Longo, Daniele, Fabio Ragazzo, Lucio Mos, et al.. (2006). Impaired arterial elasticity in young patients with white-coat hypertension. Blood Pressure Monitoring. 11(5). 243–249. 14 indexed citations
12.
Ruilope, Luís M., Daniela Heintz, Pelle Stolt, et al.. (2005). 24-hour ambulatory blood-pressure effects of valsartan & hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: A VAST sub-study. Blood Pressure Monitoring. 10(2). 85–91. 9 indexed citations
13.
14.
Palatini, Paolo, Mikołaj Winnicki, Massimo Santonastaso, et al.. (2004). Prevalence and Clinical Significance of Isolated Ambulatory Hypertension in Young Subjects Screened for Stage 1 Hypertension. Hypertension. 44(2). 170–174. 59 indexed citations
15.
16.
Winnicki, Mikołaj, Valentina Accurso, Michał Hoffmann, et al.. (2003). Physical activity and angiotensin‐converting enzyme gene polymorphism in mild hypertensives. American Journal of Medical Genetics Part A. 125A(1). 38–44. 37 indexed citations
17.
Pessina, A. C., Mario Marchesi, Lucio Mos, et al.. (2001). Efficacy, Tolerability and Influence on "Quality of Life" of Nifedipine GITS versus Amlodipine in Elderly Patients with Mild-moderate Hypertension. Blood Pressure. 10(3). 176–183. 7 indexed citations
18.
Palatini, Paolo, Paolo Mormino, Massimo Santonastaso, Lucio Mos, & Achille C. Pessina. (1999). Ambulatory blood pressure predicts end-organ damage only in subjects with reproducible recordings. Journal of Hypertension. 17(4). 465–473. 33 indexed citations
19.
Bonetti, Paola, L. Chemello, Carlo Antona, et al.. (1997). Treatment of chronic hepatitis C with interferon‐α by monitoring the response according to viraemia. Journal of Viral Hepatitis. 4(2). 107–112. 7 indexed citations
20.
Palatini, Paolo, Paolo Mormino, Cristina Canali, et al.. (1994). Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study.. Hypertension. 23(2). 211–216. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Dorigatti Breakdown of academic impact, for papers by Ann C. Hewkin Breakdown of academic impact, for papers by Alessandro Mattina Breakdown of academic impact, for papers by Wille Oigman Breakdown of academic impact, for papers by Moo‐Yong Rhee Breakdown of academic impact, for papers by Aldona Wierzbicka Breakdown of academic impact, for papers by Dion Zappe Breakdown of academic impact, for papers by Kimberly F. Stitzel Breakdown of academic impact, for papers by Annette Champion Breakdown of academic impact, for papers by Eric Judd
Rankless by CCL
2026